GM1 ganglioside treatment reduces functional deficits associated with cortical focal ischemia

This publication has 19 references indexed in Scilit:

• GM1 ganglioside reduces cognitive dysfunction after focal cortical ischemia
  Pharmacology Biochemistry and Behavior, 1990
• Neural damage in the rat thalamus after cortical infarcts.
  Stroke, 1990
• Monosialoganglioside GM1 protects against anoxia-induced neuronal death in vitro
  Experimental Neurology, 1989
• GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug.
  Stroke, 1989
• Effect of GM1 ganglioside after focal cerebral ischemia in halothane-anesthetized cats.
  Stroke, 1989
• Influence of monosialoganglioside inner ester on neurologic recovery after global cerebral ischemia in monkeys.
  Stroke, 1989
• Gangliosides in the blood plasma: levels of ganglio-series gangliosides in the plasma after administration of brain gangliosides
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
• Effect of the ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion in cats.
  Stroke, 1988
• Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function.
  Stroke, 1987
• A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.
  Stroke, 1986